Skip to Main Content

Paper Details

Predicting HLA class II antigen presentation through integrated deep learning.
Nat Biotechnol
172
2019
CD4+, CD4+ T cell, HLA class II alleles, HLA class II antigen, HLA ligand sequences, antigen genes, autoimmune disease, cancer, cancers, human, human leukocyte antigen (HLA) class II molecules, major histocompatibility complex, peptide HLA ligand sequences
Author NameAffiliation
Mark M DavisStanford University
Mark M DavisHoward Hughes Medical Institute, Stanford University
Joshua E EliasStanford University
Joshua E EliasStanford University
Russ B AltmanStanford University
Russ B AltmanStanford University
  • 1 - 6

Datasets

Release 1.2